Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Nimotop, Nimodipine

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 8 USDMF, 4 CEP/COS, 2 EU WC, 1 KDMF, 6 NDC API, 7 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

23 Drugs in Development

23 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers, 11 FDA Orange Book, 44 Europe, 1 Canada, 2 South Africa, 8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - 6MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 14 SPI Pharma, 9 DKSH, 2 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 1 Clariant, 10 Corel Pharma Chem, 1 Esteem Industries, 2 Finar, 5 Gangwal Chemicals, 3 Ideal Cures, 1 Ingredion Pharma Solutions, 10 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 3 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 14 Roquette, 7 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

42 Coating Systems & Additives, 29 Fillers, Diluents & Binders, 17 Film Formers & Plasticizers, 15 Topical, 15 Controlled & Modified Release, 15 Taste Masking, 14 Thickeners and Stabilizers, 14 Chewable & Orodispersible Aids, 12 Parenteral, 11 Direct Compression, 9 Empty Capsules, 9 Solubilizers, 8 Disintegrants & Superdisintegrants, 6 Granulation, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 3 Co-Processed Excipients, 3 API Stability Enhancers, 2 Emulsifying Agents, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 20 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 17 Regulatory FDF Prices

MARKET PLACE

10 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents

6 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Biophore India Pharmaceuticals Pvt Ltd	India	BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. Hyderabad IN	R0-CEP 2020-353 - Rev 00	Nimodipine	2022-10-25	Valid	Chemical		1245
29/11/2025	Lusochimica	Italy	LUSOCHIMICA S.P.A. Lomagna IT	CEP 2022-403 - Rev 00	Nimodipine	2024-01-24	Valid	Chemical		1245

Nimotop, Nimodipine

Nimotop, Nimodipine

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers

8 USDMF

4 CEP/COS

2 EU WC

1 KDMF

6 NDC API

7 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

23 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

66 FDF Dossiers

11 FDA Orange Book

44 Europe

1 Canada

2 South Africa

8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 3MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 6MG/ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

14 SPI Pharma

9 DKSH

2 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

5 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

11 BASF

1 Clariant

10 Corel Pharma Chem

1 Esteem Industries

2 Finar

5 Gangwal Chemicals

3 Ideal Cures

1 Ingredion Pharma Solutions

10 Kerry

3 Kima Chemical

6 Lonza Capsugel

3 Microlex e.U

2 Nomisma Healthcare

1 Novo Excipients

2 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

14 Roquette

7 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

2 The Dow Chemical Company

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

42 Coating Systems & Additives

29 Fillers, Diluents & Binders

17 Film Formers & Plasticizers

15 Topical

15 Controlled & Modified Release

15 Taste Masking

14 Thickeners and Stabilizers

14 Chewable & Orodispersible Aids

12 Parenteral

11 Direct Compression

9 Empty Capsules

9 Solubilizers

8 Disintegrants & Superdisintegrants

6 Granulation

SOLUTION;ORAL - 3MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons